North Korea possesses a rich biodiversity of alpine flora, which has historically served as the foundation for its traditional medicine. However, the transition to industrial-scale plant extract powder production has been gradual, often limited by the availability of advanced solvent recovery systems and standardization equipment.
The local market currently emphasizes self-reliance, utilizing indigenous herbs extract for basic health supplements. There is a growing demand for standardized bioactive compounds that can guarantee consistent dosage and pharmacological activity across different production batches.
Economic constraints and geopolitical factors have created a unique landscape where traditional knowledge is high, but the technical infrastructure for high-end grass extract processing is in a phase of critical modernization to align with global pharmaceutical grade standards.
